Literature DB >> 1314073

1,25(OH)2-vitamin D3, a steroid hormone that produces biologic effects via both genomic and nongenomic pathways.

A W Norman1, I Nemere, L X Zhou, J E Bishop, K E Lowe, A C Maiyar, E D Collins, T Taoka, I Sergeev, M C Farach-Carson.   

Abstract

The hormonally active form of vitamin D is 1,25(OH)2-vitamin D3 [1,25(OH)2D3]. This seco-steroid is the key mediator of the vitamin D endocrine system which produces biological effects in over 28 target tissues. In these target tissues, the biological responses may be generated both by a signal transduction mechanism which involves a nuclear receptor for 1,25(OH)2D3 that modulates gene transcription or a signal transduction pathway which involves rapid opening of Ca2+ channels which are externally located on the plasma membrane. This paper reviews the evidence in support of the pleiotropic effects of this steroid hormone and presents evidence that the receptor of the genomic effects is likely to be separate from the receptor/membrane recognition element which initiates the rapid nongenomic biological effects.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1314073     DOI: 10.1016/0960-0760(92)90349-n

Source DB:  PubMed          Journal:  J Steroid Biochem Mol Biol        ISSN: 0960-0760            Impact factor:   4.292


  26 in total

1.  Vitamin D hormone confers neuroprotection in parallel with downregulation of L-type calcium channel expression in hippocampal neurons.

Authors:  L D Brewer; V Thibault; K C Chen; M C Langub; P W Landfield; N M Porter
Journal:  J Neurosci       Date:  2001-01-01       Impact factor: 6.167

2.  Calbindins decreased after space flight.

Authors:  I N Sergeev; W B Rhoten; M D Carney
Journal:  Endocrine       Date:  1996-12       Impact factor: 3.633

Review 3.  Screening, diagnosis and treatment of osteoporosis: a brief review.

Authors:  Roberto Bernabei; Anna Maria Martone; Elena Ortolani; Francesco Landi; Emanuele Marzetti
Journal:  Clin Cases Miner Bone Metab       Date:  2014-09

4.  Distribution of the nuclear receptor for vitamin D in female and male zebra finches, Taeniopygia guttata.

Authors:  H J Bidmon; W E Stumpf
Journal:  Cell Tissue Res       Date:  1994-05       Impact factor: 5.249

5.  The rationale for deltanoids in therapy for myeloid leukemia: role of KSR-MAPK-C/EBP pathway.

Authors:  George P Studzinski; Xuening Wang; Yan Ji; Qing Wang; Yingyu Zhang; Andrzej Kutner; Jonathan S Harrison
Journal:  J Steroid Biochem Mol Biol       Date:  2005-07-25       Impact factor: 4.292

Review 6.  Genetic influences in sport and physical performance.

Authors:  Zudin Puthucheary; James R A Skipworth; Jai Rawal; Mike Loosemore; Ken Van Someren; Hugh E Montgomery
Journal:  Sports Med       Date:  2011-10-01       Impact factor: 11.136

7.  Vitamin D target systems in the brain of the green lizard Anolis carolinensis.

Authors:  H J Bidmon; W E Stumpf
Journal:  Anat Embryol (Berl)       Date:  1996-02

8.  1,25-Dihydroxyvitamin D3 binding sites in the eye and associated tissues of the green lizard Anolis carolinensis.

Authors:  H J Bidmon; W E Stumpf
Journal:  Histochem J       Date:  1995-07

9.  1 alpha,25-Dihydroxyvitamin D3 inhibits the invasive potential of human breast cancer cells in vitro.

Authors:  C M Hansen; T L Frandsen; N Brünner; L Binderup
Journal:  Clin Exp Metastasis       Date:  1994-05       Impact factor: 5.150

10.  1α,25(OH)(2)-Vitamin D3 increases dysferlin expression in vitro and in a human clinical trial.

Authors:  Noemi De Luna; Jordi Díaz-Manera; Carmen Paradas; Cristina Iturriaga; Ricardo Rojas-García; Josefa Araque; Mireia Genebriera; Ignasi Gich; Isabel Illa; Eduard Gallardo
Journal:  Mol Ther       Date:  2012-08-21       Impact factor: 11.454

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.